If you are looking into stocks to track today, then it might be a good move to look into the Northwest Biotherapeutics Inc (OTCMKTS:NWBO) stock. Yesterday, the company provided an update with regards to its Sawston, United Kingdom facility and that resulted in a 4% jump in the stock.
The biotech firm, which is working on DCVax for providing customized therapies for cancer tumors, announced yesterday that it submitted the application for the certification of the Sawston facility to the Medicines and Healthcare Products Regulatory Agency.
It is a major development for the company considering the fact that it has worked assiduously towards building this facility over the past year. As a matter of fact, work continued even when the coronavirus pandemic had been raging last year. It now remains to be seen if the Sawston facility gets the coveted certification. However, it is likely that the Northwest stock is going to be in focus among many investors.